Escalon Medical Corp.
ESMC
$0.208
$0.000.00%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 15.79% | -19.89% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.79% | -19.89% | |||
| Cost of Revenue | 5.00% | -21.59% | |||
| Gross Profit | 29.74% | -17.58% | |||
| SG&A Expenses | 5.71% | -5.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.57% | -15.76% | |||
| Operating Income | 1,047.78% | -119.52% | |||
| Income Before Tax | 863.98% | -123.96% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 863.98% | -123.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 863.98% | -123.96% | |||
| EBIT | 1,047.78% | -119.52% | |||
| EBITDA | 1,730.67% | -110.34% | |||
| EPS Basic | 372.13% | -137.20% | |||
| Normalized Basic EPS | 866.67% | -123.89% | |||
| EPS Diluted | 266.00% | -160.98% | |||
| Normalized Diluted EPS | 503.70% | -123.89% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 89.90% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
